Jones Day – MSQ Global Biopharma Symposium & Networking Event

January 7, 2024

On January 7, 2024,  San Francisco, CA, became the epicenter of the biopharmaceutical universe as Jones Day & MSQ Ventures proudly co-hosted a symposium that fosters constructive discussions among biopharma industry leaders. With the esteemed support of BioCentury Inc., The BayHelix Group,, and BioAroundWorld, this event offers a dynamic agenda with esteemed panels, inspiring company presentations, and unparalleled networking opportunities. More >

Jones Day - MSQ Global Biopharma Networking Reception in Munich

November 6, 2023

On November 6th, 2023 the Global Biopharma Networking Reception was co-hosted by Jones Day and MSQ Ventures with supporting organizations BioCentury, BayHelix, BioAroundWorld, and our co-sponsor MC Services. The event served as a platform for the industry's leading minds to showcase their innovative contributions, paving the way for the future of healthcare and biotechnology. More>

Jones Day - MSQ Global Biopharma Networking Reception

September 19, 2023

Jones Day – MSQ Ventures Global Networking Reception Shanghai, co-hosted by Jones Day and MSQ Ventures, took place on Sept 19th, 2023, at Oxbridge Centre Shanghai with supporting organizations, including BioCentury Inc., The BayHelix Group, and BioAroundWorld. More>

Global Development of Targeted Protein Degradation & Partnership Opportunities - Part 2

August 24, 2023

MSQ brought to you valuable insights into strategic partnerships and modality development in the biopharma world. The webinar was moderated by, Echo Hindle-Yang, President & CEO of MSQ Ventures, with the participation of the following distinguished speakers: More>

Global Development of Targeted Protein Degradation & Partnership Opportunities - Part 1

August 10, 2023

MSQ brought together some of the most influential figures in the field of targeted protein degradation (TPD) in our webinar “Global Development of Targeted Protein Degradation & Partnership Opportunities – Part 1”. The event was co-hosted by MSQ Ventures and BioAroundWorld. More>

MSQ-JonesDay Summit Reflection: Expert Insights from Merck, Hansoh, Panacea, Vivo Capital, Two Bear Capital, and More Regarding Cross-Border Biopharma

June 5, 2023

The Global Biopharma Cross-border Summit 2023: Boston, co-hosted by Jones Day and MSQ Ventures, took place on June 5th, 2023, at Jones Day Boston with supporting organizations, including BioCentury Inc., The BayHelix Group, and BioAroundWorld. More>

Global Biopharma Cross-border Summit 2023

MAY 16, 2023

The Global Biopharma Cross-border Summit 2023, co-hosted by PwC, MSQ Ventures, and BioKatalyst Corporation, took place on May 16th, 2023, at 300 Madison Avenue, NYC. The event brought together industry professionals, investors, and supporting organizations, including The BayHelix Group and BioAroundWorld, to discuss the latest trends and challenges in the biopharma investment landscape. More>

Global ADC Drug Development & China Opportunities

March 28, 2023

On Mar 28th, 2023, MSQ Webinar, Global ADC Drug Development & China Opportunities, brought top industry leaders and dealmakers for an exclusive event, aiming to provide participants with insights and knowledge on the latest trend of ADC drug development and how collaboration plays a key role. More>

Crossing the Golden Gate of Biopharma Partnership East-West Summit - San Francisco

January 8, 2023

The event started with the opening speeches given by Tony Chen, Partner at Jones Day, and Echo Hindle-Yang, founder and CEO of MSQ Ventures. After that, Marc Estigarribia, Managing Director of MSQ Ventures, and Ginger Ding, Managing Director of MSQ Ventures, shared MSQ’s (latest) Viewpoints on the 2023 Outlook of Cross-border Deals in China. MSQ expects cross-border licensing deals… More>

East-West Biopharma Summit Road Trip: Silicon Valley

November 11, 2022

The final leg of the East-West Biopharma Summit Road Trip took place on November 11th, 2022, in Silicon Valley. This event was co-hosted by Jones Day, BioCentury, BayHelix, BioAroundWorld, and MSQ Ventures.  

The East-West Biopharma Summit Road Trip aims to improve the exchange of innovative ideas, the latest regulatory updates, and market growth … More>

East-West Biopharma Summit Road Trip: San Diego

November 9, 2022

Following the successful New York and Boston East-West Biopharma Summit Road Trips, our third event convened on Nov 9th in San Diego. The East-West Biopharma Summit Road Trip is co-hosted by Jones Day, BioCentury, BayHelix, BioAroundWorld, and MSQ Ventures. The East-West Biopharma Summit Road Trip aims to provide a communication platform for the global biopharma industry, from both east and west, to share experiences and knowledge. More>

East-West Biopharma Summit Road Trip: Boston

October 20, 2022

Following the successful New York start-up of East-West Biopharma Summit Road Trip, our second event convened on Oct 20th in Boston. The East-West Biopharma Summit Road Trip is co-hosted by Jones Day, BioCentury, BayHelix, BioAroundWorld, and MSQ Ventures and aims to bring together leading professionals from biopharmaceutical companies to discuss biotech company opportunities this… More>

East-West Biopharma Summit Road Trip: New York

October 19, 2022

On Oct 19th, the East-West Biopharma Summit Road Trip kicked off at the first station, New York. This event was co-hosted by Jones Day, BioCentury, BayHelix, BioAroundWorld, and MSQ Ventures. People from biotech and pharmaceutical companies attended this face-to-face meeting, sharing their experiences and insights. The attendees discussed… More>

BioAroundWorld 2022 Sept Event

September 20, 2022

On Sept. 20th, the BioAroundWorld Global Cross-Border BioPharma event co-hosted by BioAroundWorld and MSQ Ventures was completed successfully virtually. This event brought us 1 panel discussion between ImaginAB and DC Pharma and more knowledge sharing presented by 5 biopharma companies. More>

BioLineRx & GenFleet Co-Development

June 29, 2022

NEW YORK, June 29, 2022, BioLineRx Ltd.(NASDAQ/TASE: BLRX), has successfully entered into a co-development agreement with GenFleet Therapeutics, Inc., an immuno-oncology focused biopharmaceutical company based in Shanghai, China, for the development of Motixafortide in pancreatic ductal adenocarcinoma ("PDAC"). More>

BioAroundWorld 2022 June Event

June 21, 2022

On June 21st, BioAroundWorld 2022 June event “Cross-Border Healthcare Innovation & Partnership” co-hosted by BioAroundWorld and MSQ Ventures was successfully held virtually. The event centered on biopharma cross-border collaboration discussion and biopharma knowledge sharing. More>

2022 BIO International Convention

June 13 - 16, 2022

BIO 2022 made us come together in person for the first time in 2 years. MSQ Ventures excitedly attended BIO 2022 and stayed in San Diego from June 12th - June 16th. We really enjoyed seeing our friends and exploring new ideas at the 2022 BIO. More>

BioAroundWorld Event April 19 & April 20

April 19 and 20, 2022

On April 19th & 20th, 2022, BioAroundWorld as the first global platform for cross-border knowledge sharing in biopharma sector successfully launched its first online even. This event brought 2 round table discussions, 3 case studies and 1 expert sharing and invited many biopharm company executives, investors and experts to share their valuable insights and successful industry experience. More>

BioAroundWorld March Interview - Joan Shen

March 8, 2022

On March 8th, 2022, we were very honored to have our guest, Dr. Joan Shen join our March Interview “Female Leader in Global Biotech Industry and Cross Region Development Collaboration”. Joan was selected by Endpoints News as one of the top 20 women in Biopharma R&D honorees 2021 and was listed as Forbes top 50 Women in Tech in China 2021.More>

3rd Annual Bio Cross-border Investment & Partnership Summit

December 16, 2021

On December 16th, the 3rd Annual Bio Cross-border Investment & Partnership Summit was successfully held virtually by MSQ Ventures and The BayHelix Group. This summit consisted of 2 panel discussions, 1 expert speech, and 12 company presentations. More>

2021 Cross-Border Healthcare Innovation & Partnership Summit

Sept 23 and 24, 2021

Sept 23 and 24, 2021: 2021 Cross-Border Healthcare Innovation & Partnership Autumn Summit was successfully held virtually by MSQ Ventures and BayHelix. This summit consisted of 2 panel discussions, 2 expert speeches, and 7 company presentations. More>

2021 4th Bio-Pharma Partnering Forum-Suzhou

June 25 and 26, 2021

June 25 and 26, 2021: 4th China Bio-Pharma Partnering Forum 2021 was successfully held in Suzhou, China, by MSQ Ventures and Healife Group. The event attracted more than 1,000 professional delegates. More than 100 business meetings and 100 leading lectures were held. More>

2021 The 21st BioEquity Europe Conference

May 18, 2021

May 18, 2021: Echo Hindle-Yang, Founder & CEO at MSQ Ventures, joined the “West-East Roundtable: Next Act Europe-China Collaborations” panel discussion at the 21st BioEquity Europe Conference, Co-hosted by BayHelix and BioCentury. More>

2021 Cross-Border Healthcare Innovation & Partnership Summit

Jan 28, 2021

2021 Cross-Border Healthcare Innovation & Partnership Summit was successfully held virtually by MSQ Ventures and BayHelix. The panel discussion and company presentations were well-received, and we were thankful to all the participants and attendants for joining this summit with us this time. More>

China and U.S. Collaboration: Innovation on the Horizon Webinar

Jan 14, 2021

Our CEO Echo Hindle-Yang joined the panel discussion “China and U.S. Collaboration: Innovation on the Horizon” organized by BioNJ and Sino-American Pharmaceutical Professionals Association (SAPA), together with panelists Lu Cao, Managing Director, JP Morgan, Stuart Peltz, CEO, PTC Therapeutics, and Lily Zou, CEO, Fosun Pharma USA. More>

BioNJ Member

Jan 2021

MSQ Ventures has become a member of BioNJ, the life sciences trade association for New Jersey, and the sole New Jersey affiliate of the Biotech Innovation Organization (BIO). MSQ Ventures will work with BioNJ together to propel the rich innovation ecosystem in the biopharmaceutical industry. More>

2nd Annual Bio Cross-border Investment & Partnership Summit 2020

Dec 18, 2020, Shanghai

The 2nd Annual Bio Cross-border Investment & Partnership Summit 2020 was successfully held in Shanghai, together with CMG-SDIC Capital (State Development & Investment Corporation) and Pharnex. Over 70+ life science executives and investors joined our team in Shanghai, and 10+ western biotech executives presented virtually during the summit. More>

BIO-Europe 2020 

Oct 26–29, 2020

Our CEO Echo Hindle-Yang hosted the BIO-EUROPE panel session "Cross-Border Partnering between Europe, US & China" by EBD Group, with panelists: Joan (Huaqiong) Shen CEO at I-Mab Biopharma, Ed Zhang Venture Partner at Hillhouse Capital Management, Shawn Singh CEO at VistaGen Therapeutics, and Robert Narquizian, Managing Director More>

2020 Cell & Gene Therapy Bioprocessing & Commercialization

Oct 19, 2020

Our Senior VP, Yun Zhao, is joining the Panel Session at Cell & Gene Therapy Bioprocessing & Commercialization at 10:00 -11:00 am Eastern Standard Time (EST), 19th October 2020. We look forward to your insightful ideas and discussions on "Investment in the CGT space: trends, technologies, and early-stage success". More>

2020 Nanjing International Summit on Innovation and Investment in New Medicine and Life Science Industry

Nanjing, September 21-23, 2020

MSQ joined the Roadshow organized by Nanjing Provincial Gov. (China) and partnered with Shenzhen Stock Exchange on Sept 23rd, with 10,000+ investors and biomedical companies attending. The roadshow is part of the 2020 Nanjing International Summit on Innovation and Investment in New Medicine and Life Science Industry. More>

CBV (CEO/ BD/ VC) Elite Training Course 

Shanghai, September 17-19, 2020

MSQ, together with Pharnex CBV and Shanghai University of Finance & Economics, hosted a quality CBV (CEO/ BD/ VC) elite training course in Shanghai. The course covered on the strategic level of Business Development, Due Diligence, Valuation Report, Contract and Agreement Term Sheet (TS), M&As, Case Studies, and the Development Trend in China Pharmaceutical Market. More>

ChinaBio Partnering Forum

Aug 25, 2020

MSQ Ventures attended ChinaBio Partnering Forum as 2020 Supporting Organization to boost partnership and cross-border innovation. ChinaBio Partnering Forum (Aug 25 - 27) where innovations meet thoughts, technologies embrace visions.

More>

China Focus@San Francisco

San Francisco, Jan 12, 2020

MSQ CEO Echo Hindle-Yang, attended the event and moderated Panel ‘AI and Novel Therapeutic Solutions’ during which she led the discussion of the world being reshaped by new tech. More>

2019 Cross-Border Healthcare Winter Summit

New York City, Dec 10, 2019

60+ industrial professionals of top healthcare companies from the US , Europe and Asia Pacific region, as well as cross-border investors, banks, and related firms attended our event. More>

Bio Cross-border Investment & Partnership Summit 2019

Shanghai, Nov 17, 2019

MSQ Ventures collaborated with our great partners, Pharnex and CMG-SDIC Capital on co-hosting the 'Bio Cross-border Investment & Partnership Summit 2019' on Nov 17 in Shanghai. More>

China Focus@Europe Hamburg

Hamburg, Nov 10, 2019

Echo Hindle-Yang, CEO at MSQ Ventures, attended China Focus@Europe Hamburg and moderated Panel 'Recipe for a successful cross-border partnership' during which she talked about China-Europe cooperation. More>

Info Session at Columbia University

New York, Oct 11, 2019

MSQ held a successful info session at Columbia University. Senior team shared their career paths and opinions on how to become a successful advisor to the clients regarding a China access strategy. More>

ESMO 2019

Barcelona, Sept 27 - Oct 1, 2019

2019 European Society of Molecular Oncology (ESMO) was around the corner! Echo Hindle-Yang, CEO at MSQ Ventures, attended and stayed in Barcelona from Sept 27th - Oct 1st, where she met our old and new friends. More>

Bio Partnering APAC 2019 Shanghai Conference

Shanghai, Sept 24-25, 2019

Bio Partnering APAC 2019 Shanghai Conference themed on “R&D Strategy Innovation under New Regulatory Policy, Collaboration Opportunity under New Global Situation.” Echo Hindle-Yang, our CEO, was invited to join the panel. More>

2019 World Nobel Laureate Biomedical Summit

China, Sept 17-22, 2019

2019 World Nobel Laureate Biomedical Summit is co-hosted by MSQ and over 2,000 financial investors and 1,000 strategic partners as well as decision makers of western healthcare companies participated in these events. More>

MSQ Healthcare Innovation NYC Roadshow

New York, Jun 20, 2019

MSQ brought 20 Chinese healthcare strategic partners/investors and western companies to generate synergy which fueled the present wealthy ecosystem of partnering/investment in the healthcare industry. More>

Rare Disease Innovation and Partnering Summit

Boston, Jun 13-14, 2019

Echo Hindle-Yang joined in the panel to share her opinions on “Investing Today in Tomorrow's Life-Transforming Treatments — Opportunities for Venture Capitalists to Move Science to Medicine” on June 13, at 2 PM (EDT). More>

SAPA-GP Liberty Bell Venture Forum RESI

Philadelphia, Jun 3, 2019

RESI is a conference series that provides a global venue for early-stage life science companies across Drugs, Devices, Diagnostics and Digital Health, to source investors, create relationships, and potentially, secure funding. More>

China Focus @BIO Philadelphia 2019 Conference

Philadelphia, Jun 2, 2019

The event brings together 100+ Chinese investors, pharma leaders, and healthcare innovators. It is designed to provide a meaningful platform to inform, inspire, and foster cross- Border partnership in life science and healthcare. More>

The 12th Annual Yao Yuan Biotech Pharma Symposium

Chicago, May 30-31, 2019

This conference established the framework to effectively translate groundbreaking discoveries to enviable assets that are attractive to capitals around the world. More>

5th Annual Immuno-Oncology BD&L and Investment Forum

Chicago, May 31, 2019

This form brought together thought leaders from cancer research institutes, patient advocacy groups, pharma and biotech to facilitate partnering, funding and investment. More>

World Advanced Therapies & Regenerative Medicine Congress (14th)

London, May 15-17, 2019

From May 15 to May 17, 2019, Echo Hindle-Yang, our CEO, joined in the 14th Annual World Advanced Therapies & Regenerative Medicine Congress in London. More>

2019 CKGSB-MSQ New York City Blockchain Innovation Summit with CKGSB

New York, May 13, 2019

On May 13th, MSQ and CKGSB co-hosted this summit and brought together professionals from top Chinese institutional funds, US regulatory/legal industry leaders and disruptive western blockchain companies to provide partnering, funding and blockchain industry insights. More>

China Focus @ Europe Vienna Partnering Opportunities with Chinese Pharma

Vienna, Mar 27, 2019

China Focus @ Europe Vienna forum attract more than 50 Chinese healthcare leading companies, investors, and Chinese executives. The forum focused on inspiring, educating and engaging cross-border investment and partnership in biopharmaceutical companies and investors globally. More>

2019 Cross-Border Healthcare Innovation Summit with PWC

New York, Feb 12, 2019

BioKatalyst and MSQ co-hosted this event, sponsored by Dorsey & Whitney and PwC. The conference aimed to bring the latest information to practitioners and individuals and provided an opportunity to be introduced to tier 1 biotechnology and pharmaceutical companies. More>

J.P. Morgan | Annual MSQ Healthcare Roadshow

New York, Jan 9, 2019

MSQ collaborated with eChinaHealth hosted a roadshow to provide opportunities for top-tier Chinese healthcare investors, as well as financial investors during the annual J.P. Morgan Healthcare Conference. More>

12th Annual European Life Sciences CEO Forum

Zurich, Feb 25, 2019

This event addressed through the main challenges for 2019 in investment, partnering and alliance management. CEOs contributed their insights in panels covering macro picture and innovation in the different therapeutic sectors. More>

Bo'ao China Cross-border Healthcare Investment Summit

Hainan, Sep 2018

MSQ hosted an Investment Tour with Top Chinese Healthcare Investors & Government Officials in Sept 2018. Over 1000 attendees from Healthcare Industry in China attended this 2-day conference. More>

Cross-border China Healthcare Investment Tour

Chengdu & Hangzhou, Sep 2018

MSQ Ventures hosted a 4-day trip in Chengdu & Hangzhou, China. Western companies had 1-1 meetings with tier 1 and tier 2 Chinese Healthcare Investors and strategic partners. Participants also had group discussion with local KOLs and explored local partnership opportunities. More>

2018 MSQ Blockchain Innovation Summit

New York, Nov 10, 2018

On November 10th, 2018, MSQ Ventures and PWC hosted its Annual Blockchain Innovation Summit in New York City. Experts from the technology industry, finance, legal, and media discussed outlook, regulations, deal structure, trends, latest applications and other related matters driving the industry. More>

MSQ 2018 Trip To China

China, Apr 2018

In April 2018, MSQ Ventures hosted several healthcare companies from North America on a trip in China. During the trip, MSQ and its clients completed in 2 major conferences and held roadshow in major cities like Beijing, Shanghai, and Wuxi. The meetings were insightful and promising. More>

MSQ Ventures Blockchain Summit

New York, Feb 2018

The summit was held by MSQ in New York from February 7 to February 8. Strategic investors from China including Vice President of Jingdong Pei Jian and the founder of Xunlei (NASDA: XNET)  Zou Shenglong. More >

MSQ Ventures Healthcare Roadshow

San Francisco, Jan 2018

MSQ Ventures hosted the 1st Annual MSQ Ventures Healthcare Roadshow in San Francisco, California. The roadshow offers rare and unique opportunities for US-based healthcare companies to connect with Chinese strategic and financial investors. More >

The US-China Trade Roundtable

New York, Nov 2017

On November 2nd, the US-China Trade Roundtable was hosted by MSQ Ventures in New York. After the event, the key officials from Shanghai government offered an advisory relationship with MSQ Ventures. More >

MSQ Ventures 2017 CEO-Investor Conference

New York, Apr 2017

MSQ Ventures 2017 CEO-Investor Conference was held at New York City on April, 17th. The conference lasted two days and attended by entrepreneurs, founders, CEOs from innovative US companies and strategic investors from China. More >

The US-China Cross-Border Biotech Roadshow

San Diego, Sep 2017

To stimulate healthcare-related technology communication and identify the opportunities of investment, MSQ Ventures also hosted the US-China Cross-Border Biotech Roadshow in San Diego, beginning from September 24th to October 1st. More >

The 4th Xixi Global Forum

Hangzhou, China, Aug 2017

On August 12th, MSQ Ventures sponsored the 4th Xixi Global Forum, an international finance forum hosted by Convergence of Financial Services Club. During the forum, MSQ Ventures co-hosted the Biotechnology and Healthcare Roundtable session and the Global Project Roadshow. More >